+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UDG Healthcare Plc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 34 Pages
  • July 2022
  • GlobalData
  • ID: 5637094
UDG Healthcare Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Our summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights


UDG Healthcare Plc (UDG), formerly United Drug plc, is a provider of outsourced commercial solutions to healthcare companies. The company offers supply chain, packaging, sales and marketing, medical and regulatory services for healthcare manufacturers and pharmaceutical retailers. The company offers contract sales outsourcing and related marketing and regulatory services; healthcare logistics based businesses; drug safety monitoring; clinical trial solutions; healthcare communications and events; outsourced packaging solutions for pharmaceutical manufacturers; drug serialization; and nursing services. UDG serves biotech and med-tech companies through its subsidiaries. The company has operations in the U.S, Europe, Australia, and Asia. UDG is headquartered in Dublin, Ireland.

UDG Healthcare Plc Key Recent Developments


May 13, 2021: CD&R to acquire UDG Healthcare for $3.7bn
May 12, 2021: UDG Healthcare: Interim report 2021
May 12, 2021: UDG Healthcare announce Interim Report 2021Strong first half performance
Jan 28, 2021: UDG Healthcare Announces Committee Changes
Jan 28, 2021: UDG Healthcare Announces Directorate Changes

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • UDG Healthcare Plc - Key Facts
  • UDG Healthcare Plc - Key Employees
  • UDG Healthcare Plc - Key Employee Biographies
  • UDG Healthcare Plc - Major Products and Services
  • UDG Healthcare Plc - History
  • UDG Healthcare Plc - Company Statement
  • UDG Healthcare Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • UDG Healthcare Plc - Business Description
  • UDG Healthcare Plc - Corporate Strategy
  • UDG Healthcare Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • UDG Healthcare Plc - Strengths
  • UDG Healthcare Plc - Weaknesses
  • UDG Healthcare Plc - Opportunities
  • UDG Healthcare Plc - Threats
  • UDG Healthcare Plc - Key Competitors
  • UDG Healthcare Plc, Recent Deals Summary
Section 3 - Company’s Recent Developments
  • May 12, 2021: UDG Healthcare: Interim report 2021
  • May 12, 2021: UDG Healthcare announce Interim Report 2021Strong first half performance
  • Jan 28, 2021: UDG Healthcare Announces Committee Changes
  • Jan 28, 2021: UDG Healthcare Announces Directorate Changes
  • Jan 26, 2021: UDG HEALTHCARE: Positive Q1 trading performance and full year guidance issued
  • Jan 26, 2021: UDG Healthcare Announces Result of Annual General Meeting
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • UDG Healthcare Plc, Key Facts
  • UDG Healthcare Plc, Key Employees
  • UDG Healthcare Plc, Key Employee Biographies
  • UDG Healthcare Plc, Major Products and Services
  • UDG Healthcare Plc, History
  • UDG Healthcare Plc, Subsidiaries
  • UDG Healthcare Plc, Key Competitors
  • UDG Healthcare Plc, Recent Deals Summary

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Movianto UK Ltd
  • McKesson Europe AG
  • Labcorp Drug Development
  • Clinigen Ltd
  • AAH Pharmaceuticals Ltd